Immunotherapy platforms to treat a variety of high-risk cancers: 1-Chimeric antigen receptors (CAR) technology that targets cell surface antigens that....
Work for Juno Therapeutics? Take ownership of your company’s profile and submit the latest details about your company to keep the investors, strategics, and service providers using our database up-to-date on the work being done at your company.
